Keywords: cosmo, first-half, results, beat, forecasts, italian, drugmaker
Cosmo's first-half 2008 results beat forecasts
Article | 11 August 2008
Italian drugmaker Cosmo Pharmaceuticals says that, in the first six months of 2008, basic and diluted loss per share narrowed 46.1% year-on-year ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Proposal to list Roche's Neulastim and Actemra in New Zealand
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
